The “Novel Vaccine Delivery Devices Market, 2019-2030” report features an extensive study of the current landscape and the likely future opportunities associated with novel vaccine delivery devices, over the next 10-12 years.


To order this 500+ page report, which features 90+ figures and 160+ tables, please visit this


Key Inclusions

  • A detailed assessment of the overall novel vaccine delivery devices market landscape, featuring an elaborate list of device developers and analysis based on a number of relevant parameters, such as year of establishment, company size, geographical location, type of device (autoinjectors, microneedle patches, jet injectors, dry powder inhalers, microinjectors, nasal delivery systems, pen injectors, biodegradable implants, electroporation-based needle free injection systems and novel oral delivery systems), route of administration (subcutaneous, transdermal, intramuscular, intradermal, inhalation, intranasal, and oral), drug delivery mechanism (mechanical, electrical and miscellaneous), nature of vaccine administration (invasive and non-invasive), speed of administration (fast, moderate and slow), self- administration potential, provisions for audio / visual feedback, device usability (disposable and reusable), type of needle (needleless, fixed needle, detachable needle, and hidden needle), and current development status of novel vaccine delivery systems (preclinical / discovery, clinical and marketed).
  • A detailed competitiveness analysis of novel vaccine delivery devices, taking into consideration the supplier power (based on the year of establishment of developer company) and key product specifications (such as route of administration, device usability, drug delivery mechanism, availability of needle safety system, speed of administration, self-administration potential, provisions for audio / visual feedback, nature of administration, cold chain requirement and current status of development).
  • An analysis evaluating the effectiveness of various vaccines delivery devices in order to compare their respective strengths and capabilities based on a variety of relevant parameters, such as type of active ingredient, dosage form, route of administration, target disease indication and target patient population.
  • A detailed list of marketed and pipeline vaccine candidates that are anticipated to be developed in combination with novel vaccine delivery devices in the near future, featuring analysis based on parameters, such as type of active ingredient, dosage form, route of administration, target disease indication and target patient population.
  • Elaborate profiles of prominent product developers engaged in this domain; each profile features a brief overview of the company, its financial information (if available), information on its product portfolio, recent developments and an informed future outlook.
  • An analysis of recent collaborations and partnership agreements inked in this domain since 2014, including details of deals that were / are focused on novel vaccine delivery devices. The partnerships captured in the report were analyzed on the basis of year of establishment, type of agreement, type of device, type of vaccine, type of active ingredient and target disease indication.
  • A discussion on important, industry-specific trends, key market drivers and challenges, under a comprehensive SWOT framework, featuring a qualitative Harvey ball analysis that highlights the relative impact of each SWOT parameter on the overall market.


The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

  • Type of device
  • Electroporation-based needle free injection system
  • Oral delivery systems
  • Nasal delivery systems
  • Jet injectors
  • Microneedle patches
  • Microinjectors


  • Route of administration
  • Oral
  • Intramuscular
  • Intranasal
  • Intradermal
  • Subcutaneous


  • Type of vaccine
  • Bivalent Oral Polio Vaccine
  • BCG Vaccine
  • DTP-HepB-Hib Vaccine
  • Pneumococcal Conjugate Vaccine
  • Influenza Vaccine
  • Measles Vaccine
  • Tetanus-Diphtheria Vaccine
  • Others


  • Key geographical regions
  • North America
  • Europe
  • Asia Pacific
  • Rest of the world


To request a sample copy / brochure of this report, please visit this


Key Questions Answered


  • Who are the leading novel vaccine delivery device developers?
  • What are the prevalent trends within competitive landscape of novel vaccine delivery devices?
  • What are the types of vaccine candidates that are suited for delivery via novel vaccine delivery devices?
  • How is the current and future market opportunity likely to be distributed across key market segments?
  • Which partnership models are commonly adopted by stakeholders in this industry?
  • How is the current and future market opportunity likely to be distributed across key market segments?


You may also be interested in the following titles:

  1. Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030
  2. Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030
  3. Large Volume Wearable Injectors Market (4th Edition), 2018-2030
  4. Global Autoinjectors Market (2nd Edition), 2018-2030



Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091




You may also like...